CN115364270A - Preparation method of antibacterial and antioxidant fiber film dressing containing traditional Chinese medicines - Google Patents
Preparation method of antibacterial and antioxidant fiber film dressing containing traditional Chinese medicines Download PDFInfo
- Publication number
- CN115364270A CN115364270A CN202210372762.9A CN202210372762A CN115364270A CN 115364270 A CN115364270 A CN 115364270A CN 202210372762 A CN202210372762 A CN 202210372762A CN 115364270 A CN115364270 A CN 115364270A
- Authority
- CN
- China
- Prior art keywords
- borneol
- fiber film
- cur
- solution
- spinning
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000835 fiber Substances 0.000 title claims abstract description 49
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 25
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 13
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 239000003963 antioxidant agent Substances 0.000 title claims description 19
- 229940126680 traditional chinese medicines Drugs 0.000 title abstract description 5
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 46
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 44
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 42
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 42
- 229940116229 borneol Drugs 0.000 claims abstract description 42
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 claims abstract description 42
- 229940109262 curcumin Drugs 0.000 claims abstract description 41
- 239000003814 drug Substances 0.000 claims abstract description 28
- 239000004632 polycaprolactone Substances 0.000 claims abstract description 25
- 229920001610 polycaprolactone Polymers 0.000 claims abstract description 25
- 235000012754 curcumin Nutrition 0.000 claims abstract description 21
- 239000004148 curcumin Substances 0.000 claims abstract description 21
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 claims abstract description 21
- 108010010803 Gelatin Proteins 0.000 claims abstract description 16
- 239000008273 gelatin Substances 0.000 claims abstract description 16
- 229920000159 gelatin Polymers 0.000 claims abstract description 16
- 235000019322 gelatine Nutrition 0.000 claims abstract description 16
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 13
- 238000010041 electrostatic spinning Methods 0.000 claims abstract description 8
- 230000008569 process Effects 0.000 claims abstract description 5
- 239000000243 solution Substances 0.000 claims description 40
- 239000012528 membrane Substances 0.000 claims description 32
- BYEAHWXPCBROCE-UHFFFAOYSA-N 1,1,1,3,3,3-hexafluoropropan-2-ol Chemical group FC(F)(F)C(O)C(F)(F)F BYEAHWXPCBROCE-UHFFFAOYSA-N 0.000 claims description 24
- 238000009987 spinning Methods 0.000 claims description 23
- 239000000499 gel Substances 0.000 claims description 14
- 239000002904 solvent Substances 0.000 claims description 10
- 230000007613 environmental effect Effects 0.000 claims description 8
- 229920002545 silicone oil Polymers 0.000 claims description 7
- 239000002121 nanofiber Substances 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 5
- 230000005684 electric field Effects 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 230000009471 action Effects 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 4
- 239000007924 injection Substances 0.000 claims description 4
- 238000003860 storage Methods 0.000 claims description 4
- 229920000642 polymer Polymers 0.000 claims description 3
- 229910000831 Steel Inorganic materials 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000010959 steel Substances 0.000 claims description 2
- 238000011049 filling Methods 0.000 claims 1
- 229940079593 drug Drugs 0.000 abstract description 15
- 206010052428 Wound Diseases 0.000 abstract description 11
- 208000027418 Wounds and injury Diseases 0.000 abstract description 11
- 238000004090 dissolution Methods 0.000 abstract description 11
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 abstract description 5
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 abstract description 5
- 241000191967 Staphylococcus aureus Species 0.000 abstract description 5
- 210000002744 extracellular matrix Anatomy 0.000 abstract description 5
- 230000009286 beneficial effect Effects 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 4
- 239000012876 carrier material Substances 0.000 abstract description 3
- 230000002401 inhibitory effect Effects 0.000 abstract description 3
- 230000003064 anti-oxidating effect Effects 0.000 abstract description 2
- 230000035876 healing Effects 0.000 abstract description 2
- 238000011031 large-scale manufacturing process Methods 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 239000000203 mixture Substances 0.000 abstract 1
- 235000006708 antioxidants Nutrition 0.000 description 17
- 230000003385 bacteriostatic effect Effects 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 239000008055 phosphate buffer solution Substances 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 235000003392 Curcuma domestica Nutrition 0.000 description 2
- 244000008991 Curcuma longa Species 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 235000003373 curcuma longa Nutrition 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000001523 electrospinning Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 239000003642 reactive oxygen metabolite Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 235000013976 turmeric Nutrition 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 201000005008 bacterial sepsis Diseases 0.000 description 1
- 229930003642 bicyclic monoterpene Natural products 0.000 description 1
- -1 bicyclic monoterpene compounds Chemical class 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 238000006065 biodegradation reaction Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/62—Compostable, hydrosoluble or hydrodegradable materials
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0015—Electro-spinning characterised by the initial state of the material
- D01D5/003—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion
- D01D5/0038—Electro-spinning characterised by the initial state of the material the material being a polymer solution or dispersion the fibre formed by solvent evaporation, i.e. dry electro-spinning
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01D—MECHANICAL METHODS OR APPARATUS IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS
- D01D5/00—Formation of filaments, threads, or the like
- D01D5/0007—Electro-spinning
- D01D5/0061—Electro-spinning characterised by the electro-spinning apparatus
-
- D—TEXTILES; PAPER
- D04—BRAIDING; LACE-MAKING; KNITTING; TRIMMINGS; NON-WOVEN FABRICS
- D04H—MAKING TEXTILE FABRICS, e.g. FROM FIBRES OR FILAMENTARY MATERIAL; FABRICS MADE BY SUCH PROCESSES OR APPARATUS, e.g. FELTS, NON-WOVEN FABRICS; COTTON-WOOL; WADDING ; NON-WOVEN FABRICS FROM STAPLE FIBRES, FILAMENTS OR YARNS, BONDED WITH AT LEAST ONE WEB-LIKE MATERIAL DURING THEIR CONSOLIDATION
- D04H1/00—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres
- D04H1/70—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres
- D04H1/72—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged
- D04H1/728—Non-woven fabrics formed wholly or mainly of staple fibres or like relatively short fibres characterised by the method of forming fleeces or layers, e.g. reorientation of fibres the fibres being randomly arranged by electro-spinning
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Textile Engineering (AREA)
- Mechanical Engineering (AREA)
- Dispersion Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a preparation method of a fiber film dressing which simultaneously contains traditional Chinese medicines of curcumin and borneol and has antibacterial and antioxidant properties, belonging to the technical field of traditional Chinese medicine preparations. According to the fiber film dressing prepared by the invention, active drugs curcumin and borneol are highly dispersed in a mixture of a carrier material gelatin and polycaprolactone, so that the dissolution rate of the drugs is effectively improved, the fiber film dressing has the effects of inhibiting staphylococcus aureus and the antioxidation characteristic, and the synergistic effect is shown after the drugs are combined. The three-dimensional porous structure with high specific surface area and high porosity can well simulate the structure of extracellular matrix, and is beneficial to realizing better healing of wounds. Can be used as an ideal and efficient wound dressing and has great application potential to wound surface wounds. Meanwhile, the preparation method adopts a solution electrostatic spinning method, has simple process, is green and efficient, has lower cost and is suitable for large-scale production.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicine preparations, and particularly relates to a preparation method of a fibrous membrane which simultaneously contains traditional Chinese medicines of curcumin and borneol and has the effects of inhibiting staphylococcus aureus and oxidation resistance.
Background
With the continuous development of material science and medicine, the traditional wound dressing can not meet the requirements of patients, and the medical dressing with special functions is applied. For biomedical wound dressings, the use of materials with antimicrobial properties would be beneficial for preventing bacterial infections, sepsis, and the like. In addition, oxidative stress is one of the factors that causes the wound healing process to be slow, causing the wound to become a chronic disease. The destruction of Reactive Oxygen Species (ROS) at the wound site is considered an important strategy to accelerate the chronic wound healing process. Therefore, drugs, growth factors and the like are added into the wound dressing as bioactive additives, so that the wound can be healed more quickly and better. Curcumin (Cur) is a yellow phenolic substance extracted from the rhizome of turmeric, is one of the main active ingredients of turmeric, and has low toxicity, antibacterial, antioxidant and anti-inflammatory properties. Borneol (Borneol), belonging to bicyclic monoterpene compounds, has antibacterial and antiinflammatory effects. Meanwhile, the transdermal absorption of insoluble drugs can be promoted, and the blood concentration and bioavailability of other drugs can be improved. However, curcumin and borneol are oil-soluble and are insoluble in water, so that the bioavailability is low, and the clinical application of curcumin and borneol is greatly limited.
The electrostatic spinning nanofiber membrane can effectively improve the dissolution rate of insoluble drugs due to the characteristics of high specific surface area and high porosity, and the structural characteristics of the electrostatic spinning nanofiber membrane are similar to those of human natural tissues, so that the structure of extracellular matrix (ECM) can be well simulated. Among the many spinnable polymers, the natural polymer gelatin (Gel) is widely used in the biomedical field due to its unique biodegradation and biocompatibility. In addition, the water absorption capacity of the gelatin is 5 to 10 times of the self weight of the gelatin, and the gelatin has good moisture absorption performance. More importantly, the gelatin contains a large amount of glycine, proline and hydroxyproline, and can accelerate wound healing. But it has poor mechanical properties. The synthetic polymer Polycaprolactone (PCL) has excellent mechanical property, biocompatibility and biodegradability, and can make up for the defect of poor mechanical property of gelatin.
Disclosure of Invention
The invention aims to design a bacteriostatic antioxidant fiber film dressing containing traditional Chinese medicines so as to improve the dissolution performance of medicines in an aqueous medium and enable the dressing to have bacteriostatic and antioxidant effects.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows:
the polymer is selected from gelatin (Gel) and Polycaprolactone (PCL), the medicine is curcumin (Cur) and Borneol (Borneol), and the solvent is Hexafluoroisopropanol (HFIP). Firstly, dissolving Gel and PCL in HFIP, then adding Cur with different masses into the solution according to the mass fractions of the Cur being 0%,1%,3%,5% and 3% in sequence, adding Borneol with different masses into the solution according to the mass fractions of Borneol being 1%,1%,1%,1% and 0% in sequence, placing the solution on a magnetic stirrer, stirring for 24 hours in the dark, and uniformly mixing to obtain the Gel/PCL/Cur/Borneol spinning solution with different concentration gradients.
The preparation method of the bacteriostatic antioxidant fiber membrane dressing containing traditional Chinese medicine is a solution electrostatic spinning method, the prepared spinning solution is filled into a 10ml medical injector, the injector is provided with a No. 21 steel needle, and the injector is fixed on a propulsion pump. The needle head is connected with a positive-pressure direct-current power supply, and the flat plate receiving device coated with the silicone oil paper is connected with a negative-pressure direct-current power supply. Starting an injection pump to push the spinning solution to advance, stretching the spinning solution under the action of an electric field force, volatilizing the solvent, solidifying the solute into filaments, and collecting the nanofiber membrane on a flat receiver. Wherein the parameters of the electrostatic spinning process are as follows: the positive pressure is 12kV, the negative pressure is 5kV, the advancing speed is 0.6ml/h, the receiving distance is 20cm, the environmental temperature is 20 ℃, the environmental humidity is 10% -30%, and the whole spinning process is protected from light.
After spinning, the fiber membrane and the silicone oil paper are placed in a constant-temperature drying oven together, dried for 24 hours at 50 ℃ to remove a solvent Hexafluoroisopropanol (HFIP) in the fiber membrane, and packaged in a sealed bag for storage.
The invention provides a preparation method of a traditional Chinese medicine-containing bacteriostatic antioxidant fibrous membrane dressing. The fiber diameter in the prepared fiber membrane is 0.5-0.7 μm, the fiber membrane has high specific surface area, high porosity and three-dimensional porous structure, and is beneficial to improving the contact area of curcumin and borneol with water, so that the dissolution rate of the medicine is improved, and the fiber membrane has excellent effects in bacteriostasis and antioxidation tests.
Compared with the prior art, the invention has the following advantages and effects
1. According to the fiber film dressing prepared by the invention, active drugs curcumin (Cur) and Borneol (Borneol) are highly dispersed in carrier materials of gelatin (Gel) and Polycaprolactone (PCL), so that the dissolution rate of the drug Cur is effectively improved, and the antibacterial property and the antioxidant property of the drug are improved.
2. The curcumin (Cur) and Borneol (Borneol) carried by the fiber film dressing prepared by the invention have antibacterial and antioxidant effects, and show synergistic effect after the drugs are combined.
3. The fiber membrane dressing provided by the invention has the advantages of high specific surface area, high porosity and three-dimensional porous structure, can well simulate the structure of extracellular matrix (ECM), and is beneficial to realizing better healing of wounds.
4. The fiber film dressing of the invention uses carrier materials of gelatin (Gel) and Polycaprolactone (PCL) which are biodegradable, and has very good practical prospect.
5. The fiber film dressing is prepared by using a solution electrostatic spinning method, and the preparation method is simple, low in cost, green, high-efficiency, easy to operate and suitable for large-scale production.
Drawings
FIG. 1 is SEM images of fiber film dressings prepared in examples 1, 2, 3 and 4 of the present invention
FIG. 2 is a graph showing in vitro dissolution profiles of the fiber film dressings prepared in examples 2, 3 and 4 of the present invention
FIG. 3 is a bacteriostatic diagram of the fiber film dressing prepared in example 3 of the present invention
FIG. 4 is a bar graph of the antioxidant performance of the fiber film dressings prepared in examples 3 and 5 of the present invention
Detailed Description
In order to explain the bacteriostatic and antioxidant fiber membrane dressing containing traditional Chinese medicine and the preparation method thereof more fully, the following specific examples of the preparation method are provided, but the invention is not limited to the examples.
Example 1:
0.35g of gelatin (Gel), 0.15g of Polycaprolactone (PCL) and 0.05g of Borneol (Borneol) are weighed out and dissolved in 5ml of Hexafluoroisopropanol (HFIP), and the obtained solution is placed on a magnetic stirrer and stirred for 24 hours to form a uniform spinning solution.
The prepared spinning solution was loaded into a 10ml medical syringe and fixed to a propeller pump using a solution electrospinning method. The flat plate receiving device coated with the silicone oil paper is connected with a positive voltage of 12kV, the needle head is connected with a negative voltage of 5kV, the distance between the needle head and the flat plate receiving device is 20cm, the environmental temperature is 20 ℃, and the environmental humidity is 10% -30%. Starting an injection pump to push the spinning solution at the advancing speed of 0.6ml/h, stretching the spinning solution under the action of an electric field force, volatilizing the solvent, solidifying the solute into filaments, and collecting the nanofiber membrane on a flat receiver.
Placing the fiber membrane and the silicone oil paper together in a constant temperature drying oven, drying at 50 deg.C for 24h to remove solvent Hexafluoroisopropanol (HFIP) in the fiber membrane, and packaging the fiber membrane in a sealed bag for storage.
Example 2:
0.35g of gelatin (Gel), 0.15g of Polycaprolactone (PCL) and 0.05g of Borneol (Borneol) are weighed and dissolved in 5ml of Hexafluoroisopropanol (HFIP), and then 0.05g of curcumin (Cur) is added to place the obtained solution on a magnetic stirrer and stir in the dark for 24h to form a uniform spinning solution.
(2) The prepared spinning solution was loaded into a 10ml medical syringe fixed to a propeller pump using a solution electrospinning method. The flat plate receiving device coated with the silicone oil paper is connected with positive pressure of 12kV, the needle head is connected with negative pressure of 5kV, the distance between the needle head and the flat plate receiving device is 20cm, the environmental temperature is 20 ℃, and the environmental humidity is 10% -30%. Starting an injection pump to push the spinning solution at the advancing speed of 0.6ml/h, stretching the spinning solution under the action of electric field force, volatilizing the solvent, solidifying the solute into filaments, collecting the nanofiber membrane on a flat receiver, and keeping the spinning process away from light as far as possible.
(3) The fiber membrane and the silicon oil paper are placed in a constant temperature drying oven together, dried for 24 hours at 50 ℃ to remove the solvent Hexafluoroisopropanol (HFIP) in the fiber membrane, and then the fiber membrane is sealed in a sealed bag for storage.
Example 3:
0.35g of gelatin (Gel), 0.15g of Polycaprolactone (PCL) and 0.05g of Borneol (Borneol) are weighed and dissolved in 5ml of Hexafluoroisopropanol (HFIP), and then 0.15g of curcumin (Cur) is added to place the obtained solution on a magnetic stirrer and stir in the dark for 24h to form a uniform spinning solution.
(2) The procedure was as in example 2.
Example 4:
0.35g of gelatin (Gel), 0.15g of Polycaprolactone (PCL) and 0.05g of Borneol (Borneol) are weighed out and dissolved in 5ml of Hexafluoroisopropanol (HFIP), and then 0.25g of curcumin (Cur) is added to stir the obtained solution on a magnetic stirrer for 24 hours in the dark to form a uniform spinning solution.
The procedure was as in example 2.
Example 5:
0.35g of gelatin (Gel) and 0.15g of Polycaprolactone (PCL) are weighed out and dissolved in 5ml of Hexafluoroisopropanol (HFIP), 0.15g of curcumin (Cur) is subsequently added and the solution is stirred on a magnetic stirrer for 24h in the dark to form a homogeneous spinning solution.
(2) The procedure was as in example 2.
SEM test characterization is carried out on the fiber film dressings prepared in the above examples 1, 2, 3 and 4, and the results show that the fibers are good in appearance and uniform in distribution. The magnified detail shows that the fiber surface is smooth and no obvious particles are present. As shown in fig. 1. With the increase of the content of curcumin (Cur), the conductivity of the solution is increased, and the solution is subjected to larger stretching force in an electric field, so that the diameter is thinned, and the diameter distribution range is 0.5-0.7 μm.
The fiber film dressings prepared in the above examples 2, 3 and 4 were subjected to in vitro dissolution measurement: respectively taking 0.005g, 0.0167g and 0.01g of the fiber membranes, immersing the fiber membranes into 100mL of PBS (containing 0.4% of Tween-80), putting the fiber membranes into a constant temperature oscillator, wherein the rotating speed of the constant temperature oscillator is 100r/min, the medium temperature is 37 ℃, sampling 4mL at regular intervals, simultaneously adding PBS (phosphate buffer solution) with the same volume and temperature, centrifuging the obtained solution at a high speed of 5000r/min, taking supernate, and measuring the absorbance of the supernate at the wavelength of 427nm by using an ultraviolet spectrophotometer to calculate the dissolution rate of curcumin (Cur). The dissolution curves shown in figure 2 are obtained, and the drug release rates of the fibrous membrane reach 66.02%,80.74% and 74.19% respectively.
The fiber film dressing prepared in the above example 3 was tested for antibacterial performance, and the fiber film obtained in the above example 3 of the present invention was selected to study the in vitro antibacterial activity against staphylococcus aureus: 100 μ L of Staphylococcus aureus suspension with a concentration of 1X 106cfu/mL was inoculated into sterilized agar, and the fibrous membrane disc obtained in example 3 above, containing 50 μ g of curcumin (Cur) by mass, was cut out, and curcumin (Cur) and Borneol (Borneo) with the same mass were dropped into the same size of disc as a control group. Sterilizing with ultraviolet rays for 30min, placing into the agar, culturing at 37 deg.C for 24 hr, and observing antibacterial effect. As shown in FIG. 3, the fibrous film dressing prepared in example 3 of the present invention has a significant inhibitory effect on Staphylococcus aureus. In addition, for the borneol-free curcumin film (C) and the borneol fiber film (B), no antibacterial activity was exhibited, which is suspected to be related to the drug concentration, and it was also demonstrated that the two had stronger antibacterial activity after combined use.
The fiber film dressings containing Borneol (Borneol) and not containing Borneol (Borneol) prepared in the above examples 3 and 5 were subjected to an antioxidant performance test, and the fiber films obtained in the above examples 3 and 5 of the present invention were selected to study the antioxidant activity: a certain amount of the above fiber membrane was immersed in 100mL of methanol: distilled water =1:1, placing the mixed solvent in a constant-temperature oscillator at the rotation speed of 100r/min and the medium temperature of 37 ℃, oscillating at the constant temperature for 24 hours to obtain a dissolution liquid, respectively taking 0.5ml, 0.75ml, 1.0ml, 1.25ml and 1.5ml of dissolution liquid in a centrifugal tube, and adding methanol: distilled water =1: the mixed solvent of 1 was made to a constant volume of 2ml to obtain curcumin concentrations of 50ppm, 75ppm, 100ppm, 125ppm and 150ppm in this order in the mixed solution, and then 3ml of 1, 1-diphenyl-2-picrylhydrazino (DPPH) solution was added, respectively. Wait for 60min. And (3) respectively measuring the absorbance of the DPPH solution and the mixed solution by using an ultraviolet spectrophotometer at the wavelength of 517nm, calculating the antioxidant efficiency of the DPPH solution and the mixed solution, and determining the optimal antioxidant drug concentration to be 125ppm. The change of the antioxidant performance of the medicine with time is measured under the concentration, and the antioxidant efficiency of the bacteriostatic antioxidant fiber membrane dressing containing Borneol (Borneol) and the antioxidant efficiency of the bacteriostatic antioxidant fiber membrane dressing not containing Borneol (Borneol) reach the maximum of 81 percent and 85 percent respectively within 180 min. Shows better antioxidant activity. In addition, the antioxidant capacity of the bornyl alcohol (Borneol) -containing fiber film dressing is higher than that of the bornyl alcohol (Borneol) -free fiber film dressing, which shows that the antioxidant capacity of the combined medicament is stronger than that of a single medicament.
Claims (1)
1. A preparation method of a traditional Chinese medicine-containing antibacterial and antioxidant fiber film dressing is characterized by comprising the following specific steps:
(1) The polymer is selected from gelatin (Gel) and Polycaprolactone (PCL), the medicine is curcumin (Cur) and Borneol (Borneol), and the solvent is Hexafluoroisopropanol (HFIP); firstly, dissolving Gel and PCL in HFIP, then adding Cur with different masses into the solution according to the mass fractions of the Cur being 0%,1%,3%,5% and 3% in sequence, adding Borneol with different masses into the solution according to the mass fractions of Borneol being 1%,1%,1%,1% and 0% in sequence, placing the solution on a magnetic stirrer, stirring for 24 hours in the dark, and uniformly mixing to prepare Gel/PCL/Cur/Borneol spinning solutions with different concentration gradients;
(2) Filling the prepared spinning solution into a 10ml medical injector, wherein the injector is provided with a 21# steel needle head, and fixing the injector on a propulsion pump; the needle head is connected with a positive-pressure direct-current power supply, and the flat plate receiving device coated with the silicone oil paper is connected with a negative-pressure direct-current power supply; starting an injection pump to push the spinning solution to advance, stretching the spinning solution under the action of an electric field force, volatilizing a solvent, solidifying a solute into filaments, and collecting a nanofiber membrane on a flat receiver; wherein the electrostatic spinning parameters are as follows: the positive pressure is 12kV, the negative pressure is 5kV, the propelling speed is 0.6ml/h, the receiving distance is 20cm, the environmental temperature is 20 ℃, the environmental humidity is 10-30%, and the whole electrostatic spinning process is protected from light;
(3) After spinning, the fiber membrane and the silicone oil paper are placed in a constant-temperature drying oven together, dried for 24 hours at 50 ℃ to remove a solvent Hexafluoroisopropanol (HFIP) in the fiber membrane, and packaged in a sealed bag for storage.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210372762.9A CN115364270A (en) | 2022-04-11 | 2022-04-11 | Preparation method of antibacterial and antioxidant fiber film dressing containing traditional Chinese medicines |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210372762.9A CN115364270A (en) | 2022-04-11 | 2022-04-11 | Preparation method of antibacterial and antioxidant fiber film dressing containing traditional Chinese medicines |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115364270A true CN115364270A (en) | 2022-11-22 |
Family
ID=84060091
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210372762.9A Pending CN115364270A (en) | 2022-04-11 | 2022-04-11 | Preparation method of antibacterial and antioxidant fiber film dressing containing traditional Chinese medicines |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115364270A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116459381A (en) * | 2023-04-04 | 2023-07-21 | 山东大学 | PH-sensitive type chronic wound medical dressing with unidirectional liquid guiding function and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102284012A (en) * | 2011-08-09 | 2011-12-21 | 临沂大学 | Gel plaster containing curcumin and bletilla hyacinthina gum and preparation method thereof |
CN109381732A (en) * | 2017-08-03 | 2019-02-26 | 国家纳米科学中心 | Electrostatic spinning dressing, preparation method and the application of growth factor-loaded micromolecular inhibitor |
-
2022
- 2022-04-11 CN CN202210372762.9A patent/CN115364270A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102284012A (en) * | 2011-08-09 | 2011-12-21 | 临沂大学 | Gel plaster containing curcumin and bletilla hyacinthina gum and preparation method thereof |
CN109381732A (en) * | 2017-08-03 | 2019-02-26 | 国家纳米科学中心 | Electrostatic spinning dressing, preparation method and the application of growth factor-loaded micromolecular inhibitor |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN116459381A (en) * | 2023-04-04 | 2023-07-21 | 山东大学 | PH-sensitive type chronic wound medical dressing with unidirectional liquid guiding function and preparation method thereof |
CN116459381B (en) * | 2023-04-04 | 2024-03-29 | 山东大学 | PH-sensitive type chronic wound medical dressing with unidirectional liquid guiding function and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Huang et al. | Exploration of the antibacterial and wound healing potential of a PLGA/silk fibroin based electrospun membrane loaded with zinc oxide nanoparticles | |
Zhang et al. | Layered nanofiber sponge with an improved capacity for promoting blood coagulation and wound healing | |
Li et al. | A promising wound dressing material with excellent cytocompatibility and proangiogenesis action for wound healing: Strontium loaded Silk fibroin/Sodium alginate (SF/SA) blend films | |
Zhang et al. | A composite hydrogel of chitosan/heparin/poly (γ-glutamic acid) loaded with superoxide dismutase for wound healing | |
Chen et al. | Curcumin-loaded sandwich-like nanofibrous membrane prepared by electrospinning technology as wound dressing for accelerate wound healing | |
Pei et al. | Effectively promoting wound healing with cellulose/gelatin sponges constructed directly from a cellulose solution | |
Qian et al. | Polydimethylsiloxane incorporated with reduced graphene oxide (rGO) sheets for wound dressing application: Preparation and characterization | |
Tang et al. | Highly absorbent bio-sponge based on carboxymethyl chitosan/poly-γ-glutamic acid/platelet-rich plasma for hemostasis and wound healing | |
CN107823692B (en) | Wound dressing composite nanofiber membrane and preparation method thereof | |
Zhang et al. | pH-sensitive alginate hydrogel for synergistic anti-infection | |
Zhang et al. | Fabrication of green poly (vinyl alcohol) nanofibers using natural deep eutectic solvent for fast-dissolving drug delivery | |
CN109224116A (en) | A kind of the antibacterial anti hemorrhagic medical dressing and preparation method of high-absorbable | |
Ding et al. | A multifunctional supramolecular hydrogel for infected wound healing | |
Luo et al. | Bioactive rare earth-based inorganic-organic hybrid biomaterials for wound healing and repair | |
CN115364270A (en) | Preparation method of antibacterial and antioxidant fiber film dressing containing traditional Chinese medicines | |
AU2013306517B2 (en) | Active polymer layer made of chitin derivatives, especially for a dressing, and its use | |
Lv et al. | Gelatin-based nanofiber membranes loaded with curcumin and borneol as a sustainable wound dressing | |
Mirjalili et al. | Controlled release of protein from gelatin/chitosan hydrogel containing platelet-rich fibrin encapsulated in chitosan nanoparticles for accelerated wound healing in an animal model | |
Agnes Mary et al. | In vivo bioactivity of herbal‐drug‐incorporated nanofibrous matrixes | |
CN115154642A (en) | Bionic asymmetric sponge dressing and preparation method thereof | |
Wang et al. | Antibacterial, anti-inflammatory, rapid hemostasis, and accelerated repair by multifunctional metal–organic frameworks fibrous scaffolds for diabetic wounds | |
Kim et al. | PCL/gelatin nanofibers incorporated with starfish polydeoxyribonucleotides for potential wound healing applications | |
CN116942883B (en) | Bionic fiber membrane for promoting healing of diabetic wounds and preparation method and application thereof | |
CN108939141A (en) | It is a kind of for the Chinese medicine composite porous support material and preparation method of burn wound healing and application | |
Wu et al. | A self-assembled hydrogel dressing as multi-target therapeutics to promote wound healing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20221122 |
|
RJ01 | Rejection of invention patent application after publication |